University of Birmingham Defining the balance between regeneration and pathological ossification in skeletal muscle following traumatic injury

Heterotopic ossification (HO) is characterized by the formation of bone at atypical sites. This type of ectopic bone formation is most prominent in skeletal muscle, most frequently resulting as a consequence of physical trauma and associated with aberrant tissue regeneration. The condition is debilitating, reducing a patient’s range of motion and potentially causing severe pathologies resulting from nerve and vascular compression. Despite efforts to understand the pathological processes governing HO, there remains a lack of consensus regarding the micro-environmental conditions conducive to its formation, and attempting to define the balance between muscle regeneration and pathological ossification remains complex. The development of HO is thought to be related to a complex interplay between factors released both locally and systemically in response to trauma. It develops as skeletal muscle undergoes significant repair and regeneration, and is likely to result from the misdirected differentiation of endogenous or systemically derived progenitors in response to biochemical and/or environmental cues. The process can be sequentially delineated by the presence of inflammation, tissue breakdown, adipogenesis, hypoxia, neo-vasculogenesis, chondrogenesis and ossification. However, exactly how each of these stages contributes to the formation of HO is at present not well understood. Our previous review examined the cellular contribution to HO. Therefore, the principal aim of this review will be to comprehensively outline changes in the local tissue micro-environment following trauma, and identify how these changes can alter the balance between skeletal muscle regeneration and ectopic ossification. An understanding of the mechanisms governing this condition is required for the development and advancement of HO prophylaxis and treatment, and may even hold the key to unlocking novel methods for engineering hard tissues. with HO. Under normoxic conditions HIF1 α is polyubiquitinated and proteasomally degraded. Under hypoxic conditions HIF1 α localizes with HIF1 β to form a transcription complex that promotes the synthesis of target genes related to angiogenesis, endothelial-mesenchymal transition (EndMT), tissue breakdown and remodeling, energy metabolism, and chondrogenesis.

[1]  C. Aguilar,et al.  RNA transcript expression of IGF-I/PI3K pathway components in regenerating skeletal muscle is sensitive to initial injury intensity. , 2017, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[2]  L. Grover,et al.  Identifying the Cellular Mechanisms Leading to Heterotopic Ossification , 2015, Calcified Tissue International.

[3]  Michael D. Schneider,et al.  Monocyte/Macrophage-derived IGF-1 Orchestrates Murine Skeletal Muscle Regeneration and Modulates Autocrine Polarization. , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

[4]  Wei Huang,et al.  HIF-1α as a Regulator of BMP2-Induced Chondrogenic Differentiation, Osteogenic Differentiation, and Endochondral Ossification in Stem Cells , 2015, Cellular Physiology and Biochemistry.

[5]  P. Robbins,et al.  NF-κB inhibition reveals a novel role for HGF during skeletal muscle repair , 2015, Cell Death and Disease.

[6]  C. Dani,et al.  Characterization of adipocytes derived from fibro/adipogenic progenitors resident in human skeletal muscle , 2015, Cell Death and Disease.

[7]  U. Smith,et al.  BMP4 and BMP Antagonists Regulate Human White and Beige Adipogenesis , 2015, Diabetes.

[8]  T. Oda,et al.  Expression of tenocyte lineage-related factors in regenerated tissue at sites of tendon defect , 2014, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[9]  M. Wendel,et al.  Reciprocal effects of Interferon-γ and IL-4 on differentiation to osteoclast-like cells by RANKL or LPS. , 2014, Oral diseases.

[10]  E. Barton,et al.  Optimizing IGF-I for skeletal muscle therapeutics. , 2014, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[11]  Jonathan R. Peterson,et al.  Treatment of heterotopic ossification through remote ATP hydrolysis , 2014, Science Translational Medicine.

[12]  N. Baldini,et al.  Exosomes: novel effectors of human platelet lysate activity. , 2014, European cells & materials.

[13]  S. Sawano,et al.  Implication of anti-inflammatory macrophages in regenerative moto-neuritogenesis: promotion of myoblast migration and neural chemorepellent semaphorin 3A expression in injured muscle. , 2014, The international journal of biochemistry & cell biology.

[14]  Y. Kim,et al.  Interleukin‐6 induces the lineage commitment of bone marrow‐derived mesenchymal multipotent cells through down‐regulation of Sox2 by osteogenic transcription factors , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  Qing-Jun Meng,et al.  Gremlin-2 is a BMP antagonist that is regulated by the circadian clock , 2014, Scientific Reports.

[16]  P. Rovere-Querini,et al.  Macrophage Plasticity in Skeletal Muscle Repair , 2014, BioMed research international.

[17]  Chun-yan Hao,et al.  Effect on the expression of VEGF and HIF‐1 alpha in atherosclerosis rat myocardial with oral HSP60 (618.8) , 2014 .

[18]  Kevin M. Curtis,et al.  Hepatocyte growth factor and p38 promote osteogenic differentiation of human mesenchymal stem cells. , 2014, Molecular endocrinology.

[19]  L. Sidney,et al.  Comparison of osteogenic differentiation of embryonic stem cells and primary osteoblasts revealed by responses to IL-1β, TNF-α, and IFN-γ. , 2014, Stem cells and development.

[20]  H. Tomioka,et al.  Unique Macrophages Different from M1/M2 Macrophages Inhibit T Cell Mitogenesis while Upregulating Th17 Polarization , 2014, Scientific Reports.

[21]  O. Sigurjonsson,et al.  The Effect of Recombinant Human Interleukin-6 on Osteogenic Differentiation and YKL-40 Expression in Human, Bone Marrow–Derived Mesenchymal Stem Cells , 2014, BioResearch open access.

[22]  T. Koh,et al.  Macrophage activation and skeletal muscle healing following traumatic injury , 2014, The Journal of pathology.

[23]  P. Kloen,et al.  BMP-9 expression in human traumatic heterotopic ossification: a case report , 2013, Skeletal Muscle.

[24]  C. Benoist,et al.  A Special Population of Regulatory T Cells Potentiates Muscle Repair , 2013, Cell.

[25]  Je-Yong Choi,et al.  Role of interleukin-10 in endochondral bone formation in mice: anabolic effect via the bone morphogenetic protein/Smad pathway. , 2013, Arthritis and rheumatism.

[26]  L. Larsson,et al.  The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass , 2013, The Journal of cell biology.

[27]  G. Semenza,et al.  Role of hypoxia-inducible factors in breast cancer metastasis. , 2013, Future oncology.

[28]  P. Beck‐Peccoz,et al.  Screening for GNAS genetic and epigenetic alterations in progressive osseous heteroplasia: first Italian series. , 2013, Bone.

[29]  Min Chen,et al.  Activation of Hedgehog signaling by loss of GNAS causes heterotopic ossification , 2013, Nature Medicine.

[30]  G. Enikolopov,et al.  Role of pericytes in skeletal muscle regeneration and fat accumulation. , 2013, Stem cells and development.

[31]  Christian Stockmann,et al.  Myeloid Hypoxia-Inducible Factor-1α Is Essential for Skeletal Muscle Regeneration in Mice , 2013, The Journal of Immunology.

[32]  L. Larkin,et al.  TGF‐β1 enhances contractility in engineered skeletal muscle , 2013, Journal of tissue engineering and regenerative medicine.

[33]  G. Wanner,et al.  Use of Imatinib in the Prevention of Heterotopic Ossification , 2013, HSS Journal ®.

[34]  P. Delafontaine,et al.  The therapeutic potential of IGF-I in skeletal muscle repair , 2013, Trends in Endocrinology & Metabolism.

[35]  G. Wanner,et al.  Echinomycin in the prevention of heterotopic ossification - an experimental antibiotic agent shows promising results in a murine model. , 2013, Injury.

[36]  L. Tang,et al.  Tumor necrosis factor α suppresses the mesenchymal stem cell osteogenesis promoter miR‐21 in estrogen deficiency–induced osteoporosis , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[37]  M. Kjaer,et al.  Differentially Activated Macrophages Orchestrate Myogenic Precursor Cell Fate During Human Skeletal Muscle Regeneration , 2013, Stem cells.

[38]  Xiaonan H. Wang,et al.  Interleukin-6/Signal Transducer and Activator of Transcription 3 (STAT3) Pathway Is Essential for Macrophage Infiltration and Myoblast Proliferation during Muscle Regeneration* , 2012, The Journal of Biological Chemistry.

[39]  E. Elster,et al.  Inflammatory Cytokine and Chemokine Expression is Associated With Heterotopic Ossification in High-Energy Penetrating War Injuries , 2012, Journal of orthopaedic trauma.

[40]  Judy E. Anderson,et al.  Time-coordinated prevalence of extracellular HGF, FGF2 and TGF-β3 in crush-injured skeletal muscle. , 2012, Animal science journal = Nihon chikusan Gakkaiho.

[41]  J. Tidball,et al.  IL-10 Triggers Changes in Macrophage Phenotype That Promote Muscle Growth and Regeneration , 2012, The Journal of Immunology.

[42]  D. Medici,et al.  The role of endothelial‐mesenchymal transition in heterotopic ossification , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[43]  T. He,et al.  Growth hormone synergizes with BMP9 in osteogenic differentiation by activating the JAK/STAT/IGF1 pathway in murine multilineage cells , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[44]  Michael N. Wosczyna,et al.  Multipotent progenitors resident in the skeletal muscle interstitium exhibit robust BMP‐dependent osteogenic activity and mediate heterotopic ossification , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[45]  M. Hamrick The skeletal muscle secretome: an emerging player in muscle-bone crosstalk. , 2012, BoneKEy reports.

[46]  K. Matsuo,et al.  Bone cell interactions through Eph/ephrin , 2012, Cell adhesion & migration.

[47]  A. Sbarbati,et al.  The vascular endothelium of the adipose tissue gives rise to both white and brown fat cells. , 2012, Cell metabolism.

[48]  S. Brooks,et al.  Transforming growth factor‐beta induces skeletal muscle atrophy and fibrosis through the induction of atrogin‐1 and scleraxis , 2012, Muscle & nerve.

[49]  M. Dickinson,et al.  Sensory nerve induced inflammation contributes to heterotopic ossification , 2011, Journal of cellular biochemistry.

[50]  R. Tuan,et al.  Cytokine expression in muscle following traumatic injury , 2011, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[51]  A. Caudrillier,et al.  Cell-specific effects of TNF-α and IL-1β on alkaline phosphatase: implication for syndesmophyte formation and vascular calcification , 2011, Laboratory Investigation.

[52]  A. Davis,et al.  Matrix metalloproteinase-9 is a diagnostic marker of heterotopic ossification in a murine model. , 2011, Tissue engineering. Part A.

[53]  A. Faggiano,et al.  The roles of parathyroid hormone in bone remodeling: prospects for novel therapeutics. , 2011, Journal of endocrinological investigation.

[54]  F. Giorgino,et al.  p66Shc, a multifaceted protein linking Erk signalling, glucose metabolism, and oxidative stress , 2011, Archives of physiology and biochemistry.

[55]  N. Faucheux,et al.  BMP‐9‐induced muscle heterotopic ossification requires changes to the skeletal muscle microenvironment , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[56]  D. Zou,et al.  In vitro study of enhanced osteogenesis induced by HIF‐1α‐transduced bone marrow stem cells , 2011, Cell proliferation.

[57]  I. Loell,et al.  Can muscle regeneration fail in chronic inflammation: a weakness in inflammatory myopathies? , 2011, Journal of internal medicine.

[58]  S. Shintani,et al.  Enhancement of bone morphogenetic protein-2-induced ectopic bone formation by transforming growth factor-β1. , 2011, Tissue engineering. Part A.

[59]  C. Niesler,et al.  TGF-β isoforms inhibit IGF-1-induced migration and regulate terminal differentiation in a cell-specific manner , 2011, Journal of Muscle Research and Cell Motility.

[60]  J. Kessler,et al.  Animal Models of Typical Heterotopic Ossification , 2010, Journal of biomedicine & biotechnology.

[61]  C. Farquharson,et al.  The effect of GH and IGF1 on linear growth and skeletal development and their modulation by SOCS proteins. , 2010, The Journal of endocrinology.

[62]  Li Yang,et al.  Synergistic effects of FGF-2 and PDGF-BB on angiogenesis and muscle regeneration in rabbit hindlimb ischemia model. , 2010, Microvascular research.

[63]  L. Filgueira,et al.  Functional and proteomic analysis of serum and cerebrospinal fluid derived from patients with traumatic brain injury: a pilot study , 2010, ANZ journal of surgery.

[64]  Joshua A. Gargac,et al.  The sequential production profiles of growth factors and their relations to bone volume in ossifying bone marrow explants. , 2010, Tissue engineering. Part A.

[65]  L. Filgueira,et al.  Serum after traumatic brain injury increases proliferation and supports expression of osteoblast markers in muscle cells. , 2010, The Journal of bone and joint surgery. American volume.

[66]  Yong Li,et al.  Conditional TGF-β1 treatment increases stem cell-like cell population in myoblasts , 2010, Journal of cellular and molecular medicine.

[67]  R. T. Ballock,et al.  Thyroid Hormone-Mediated Growth and Differentiation of Growth Plate Chondrocytes Involves IGF-1 Modulation of β-Catenin Signaling , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[68]  Dan Cao,et al.  Expression of HIF-1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implications , 2009, BMC Cancer.

[69]  Eric A. Elster,et al.  Inflammatory Biomarkers in Combat Wound Healing , 2009, Annals of surgery.

[70]  S. Pill,et al.  Heterotopic Ossification Following Traumatic Brain Injury and Spinal Cord Injury , 2009, The Journal of the American Academy of Orthopaedic Surgeons.

[71]  Yong Li,et al.  Role of matrix metalloproteinases in skeletal muscle , 2009, Cell adhesion & migration.

[72]  K. Muroya,et al.  Ectopic Calcification as Discernible Manifestation in Neonates with Pseudohypoparathyroidism Type 1a , 2009, International journal of endocrinology.

[73]  M. Koutsilieris,et al.  Expression of IGF-1 isoforms after exercise-induced muscle damage in humans: characterization of the MGF E peptide actions in vitro. , 2009, In vivo.

[74]  M. Lek,et al.  Myoblast sensitivity and fibroblast insensitivity to osteogenic conversion by BMP-2 correlates with the expression of Bmpr-1a , 2009, BMC musculoskeletal disorders.

[75]  Andrew D. A. Maidment,et al.  Identification of progenitor cells that contribute to heterotopic skeletogenesis. , 2009, The Journal of bone and joint surgery. American volume.

[76]  L. Filgueira,et al.  Humoral factors enhance fracture-healing and callus formation in patients with traumatic brain injury. , 2009, The Journal of bone and joint surgery. American volume.

[77]  T. Einhorn,et al.  Heterotopic ossification after the use of commercially available recombinant human bone morphogenetic proteins in four patients. , 2008, The Journal of bone and joint surgery. British volume.

[78]  R. Pignolo,et al.  Diagnostic and mutational spectrum of progressive osseous heteroplasia (POH) and other forms of GNAS‐based heterotopic ossification , 2008, American journal of medical genetics. Part A.

[79]  Kou-Juey Wu,et al.  TWIST activation by hypoxia inducible factor-1 (HIF-1): Implications in metastasis and development , 2008, Cell cycle.

[80]  F. Booth,et al.  Examination of FGF2‐dependent proliferation in muscle precursor cells isolated from 3‐mo‐old and 32‐mo‐old rats: Implication for regrowth, repair, and regeneration of skeletal muscle , 2008 .

[81]  R. Rabin,et al.  Statins Decrease Expression of the Proinflammatory Neuropeptides Calcitonin Gene-Related Peptide and Substance P in Sensory Neurons , 2008, Journal of Pharmacology and Experimental Therapeutics.

[82]  E. Elster,et al.  Correlation of procalcitonin and cytokine expression with dehiscence of wartime extremity wounds. , 2008, The Journal of bone and joint surgery. American volume.

[83]  C. Ward,et al.  A functional insulin‐like growth factor receptor is not necessary for load‐induced skeletal muscle hypertrophy , 2008, The Journal of physiology.

[84]  S. Majumdar,et al.  IGF‐I Receptor Is Required for the Anabolic Actions of Parathyroid Hormone on Bone , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[85]  R. Orrell,et al.  The IGF‐I splice variant MGF increases progenitor cells in ALS, dystrophic, and normal muscle , 2007, FEBS letters.

[86]  Chao Wan,et al.  The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. , 2007, The Journal of clinical investigation.

[87]  G. Bassez,et al.  Muscle satellite cells and endothelial cells: close neighbors and privileged partners. , 2007, Molecular biology of the cell.

[88]  A. Davis,et al.  Hypoxic adipocytes pattern early heterotopic bone formation. , 2007, The American journal of pathology.

[89]  J. Davis,et al.  Ovarian hormone status and skeletal muscle inflammation during recovery from disuse in rats , 2007, Experimental physiology.

[90]  D. Lorich,et al.  Early changes in prostaglandins precede bone formation in a rabbit model of heterotopic ossification. , 2006, Bone.

[91]  M. Phillip,et al.  Endocrine Regulation of the Growth Plate , 2005, Hormone Research in Paediatrics.

[92]  A. Mobasheri,et al.  Hypoxia inducible factor-1 and facilitative glucose transporters GLUT1 and GLUT3: putative molecular components of the oxygen and glucose sensing apparatus in articular chondrocytes. , 2005, Histology and histopathology.

[93]  S. Colla,et al.  IL-3 is a potential inhibitor of osteoblast differentiation in multiple myeloma. , 2005, Blood.

[94]  D. Cooper,et al.  IL-6-induced skeletal muscle atrophy. , 2005, Journal of applied physiology.

[95]  G. Shefer,et al.  Skeletal muscle satellite cells can spontaneously enter an alternative mesenchymal pathway , 2004, Journal of Cell Science.

[96]  Toshio Yamamoto,et al.  Immunolocalization of Vascular Endothelial Growth Factor During Heterotopic Bone Formation Induced From Grafted Periosteum , 2004, Annals of plastic surgery.

[97]  W. Maloney,et al.  Stimulation of BMP-2 Expression by Pro-Inflammatory Cytokines IL-1 and TNF-&agr; in Normal and Osteoarthritic Chondrocytes , 2003, The Journal of bone and joint surgery. American volume.

[98]  R. Mitchell,et al.  Interferon Gamma Modulates Trauma-Induced Muscle Wasting and Immune Dysfunction , 2002, Annals of surgery.

[99]  G. Adams Invited Review: Autocrine/paracrine IGF-I and skeletal muscle adaptation. , 2002, Journal of applied physiology.

[100]  S. Majumdar,et al.  Insulin‐Like Growth Factor I Is Required for the Anabolic Actions of Parathyroid Hormone on Mouse Bone , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[101]  Johnny Huard,et al.  BMP4-expressing muscle-derived stem cells differentiate into osteogenic lineage and improve bone healing in immunocompetent mice. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[102]  A. Hattori,et al.  Mechanical stretch induces activation of skeletal muscle satellite cells in vitro. , 2001, Experimental cell research.

[103]  J. Wozney,et al.  Runx2 Is a Common Target of Transforming Growth Factor β1 and Bone Morphogenetic Protein 2, and Cooperation between Runx2 and Smad5 Induces Osteoblast-Specific Gene Expression in the Pluripotent Mesenchymal Precursor Cell Line C2C12 , 2000, Molecular and Cellular Biology.

[104]  M. Morgan,et al.  Gelatinase-B (Matrix Metalloproteinase-9; MMP-9) secretion is involved in the migratory phase of human and murine muscle cell cultures , 2000, Journal of Muscle Research & Cell Motility.

[105]  C. López-Otín,et al.  Collagenase 3 Is a Target of Cbfa1, a Transcription Factor of the runt Gene Family Involved in Bone Formation , 1999, Molecular and Cellular Biology.

[106]  G. Finkel,et al.  Bone morphogenetic protein 2/4 in early fibromatous lesions of fibrodysplasia ossificans progressiva. , 1997, Human pathology.

[107]  Y. Kim,et al.  Serial measurement of interleukin-6, transforming growth factor-beta, and S-100 protein in patients with acute stroke. , 1996, Stroke.

[108]  A. Reddi,et al.  Thyroxine is the serum factor that regulates morphogenesis of columnar cartilage from isolated chondrocytes in chemically defined medium , 1994, The Journal of cell biology.

[109]  L. Ahrengart Periarticular heterotopic ossification after total hip arthroplasty. Risk factors and consequences. , 1991, Clinical orthopaedics and related research.

[110]  L. Ahrengart Periarticular Heterotopic Ossification After Total Hip Arthroplasty , 2018 .

[111]  Judy E. Anderson Hepatocyte Growth Factor and Satellite Cell Activation. , 2016, Advances in experimental medicine and biology.

[112]  T. Schulz,et al.  Adipogenic fate commitment of muscle-derived progenitor cells: isolation, culture, and differentiation. , 2014, Methods in molecular biology.

[113]  J. Hirschhorn,et al.  A novel deletion of IGF1 in a patient with idiopathic short stature provides insight Into IGF1 haploinsufficiency. , 2014, The Journal of clinical endocrinology and metabolism.

[114]  A. Zankl,et al.  A report of three patients with MMP2 associated hereditary osteolysis. , 2012, Genetic counseling.

[115]  D. Mozingo Biomarkers to Predict Wound Healing: The Future of Complex War Wound Management , 2011 .

[116]  B. Malissen,et al.  Pax 7-expressing satellite cells are indispensable for adult skeletal muscle regeneration , 2011 .

[117]  R. Pignolo,et al.  Circulating osteogenic precursor cells. , 2010, Critical reviews in eukaryotic gene expression.

[118]  R. Kalluri,et al.  Conversion of vascular endothelial cells into multipotent stem-like cells , 2010, Nature Medicine.

[119]  N. Chen,et al.  Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion. , 2010, Journal of neurosurgery. Spine.

[120]  M. Zimowska,et al.  Distinct patterns of MMP-9 and MMP-2 activity in slow and fast twitch skeletal muscle regeneration in vivo. , 2008, The International journal of developmental biology.

[121]  P. Muñoz-Cánoves,et al.  Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. , 2008, Cell metabolism.

[122]  Yi-Ping Li,et al.  TNF-alpha regulates myogenesis and muscle regeneration by activating p38 MAPK. , 2007, American journal of physiology. Cell physiology.

[123]  M. Netea,et al.  The role of TNF- a in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk , 2007 .

[124]  D.M.Sci. Finn Gottrup M.D. Oxygen in Wound Healing and Infection , 2003, World Journal of Surgery.

[125]  N. Takahashi,et al.  Bone Morphogenetic Protein-2 Converts the Differentiation Pathway of C2C12 Myoblasts into the Osteoblast Lineage , 2002 .

[126]  T. Morgan,et al.  Transforming growth factor beta 1 and fibronectin messenger RNA in rat brain: responses to injury and cell-type localization. , 1993, Neuroscience.